Financial reports
10-Q
2021 Q1
Quarterly report
5 May 21
10-K
2020 FY
Annual report
4 Mar 21
10-Q
2020 Q3
Quarterly report
5 Nov 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
10-Q
2020 Q1
Quarterly report
7 May 20
10-K
2019 FY
Annual report
16 Mar 20
10-Q
2019 Q3
Quarterly report
5 Nov 19
10-Q
2019 Q2
Quarterly report
8 Aug 19
10-Q
2019 Q1
Quarterly report
9 May 19
10-K
2018 FY
Annual report
8 Mar 19
Current reports
8-K
Appoints Raj Kannan and Dr. Roni Mamluk as Non-Executive Directors
5 Aug 21
8-K
Submission of Matters to a Vote of Security Holders
3 Aug 21
8-K
Other Events
2 Jul 21
8-K
Other Events
22 Jun 21
8-K
Voting and Transaction Support Agreement
5 May 21
8-K
Chiasma Reports First Quarter Financial Results and Announced Agreement to Merge with Amryt
5 May 21
8-K
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
5 May 21
8-K
Chiasma Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update
4 Mar 21
8-K
Chiasma Announces Hiring of John Doyle as Chief Financial Officer
19 Jan 21
8-K
Chiasma Provides Corporate Update and Previews Expected 2021 Milestones
6 Jan 21
Registration and prospectus
15-12B
Securities registration termination
11 Aug 21
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Aug 21
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Aug 21
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Aug 21
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Aug 21
S-8 POS
Registration of securities for employees (post-effective amendment)
6 Aug 21
POS AM
Prospectus update (post-effective amendment)
6 Aug 21
25-NSE
Exchange delisting
5 Aug 21
425
Business combination disclosure
28 Jul 21
425
Business combination disclosure
2 Jul 21
Proxies
DEFA14A
Additional proxy soliciting materials
22 Jul 21
DEFM14A
Proxy related to merger
2 Jul 21
DEFA14A
Additional proxy soliciting materials
26 Apr 21
DEF 14A
Definitive proxy
26 Apr 21
DEFA14A
Additional proxy soliciting materials
28 Apr 20
DEF 14A
Definitive proxy
28 Apr 20
DEFA14A
Additional proxy soliciting materials
5 Jun 19
DEFA14A
Additional proxy soliciting materials
29 Apr 19
DEF 14A
Definitive proxy
29 Apr 19
DEF 14A
Definitive proxy
24 Apr 18
Other
EFFECT
Notice of effectiveness
12 Aug 21
EFFECT
Notice of effectiveness
26 Sep 19
CORRESP
Correspondence with SEC
23 Sep 19
CORRESP
Correspondence with SEC
17 Sep 19
UPLOAD
Letter from SEC
12 Sep 19
EFFECT
Notice of effectiveness
4 May 18
CORRESP
Correspondence with SEC
2 May 18
EFFECT
Notice of effectiveness
15 Jul 15
CORRESP
Correspondence with SEC
13 Jul 15
CORRESP
Correspondence with SEC
13 Jul 15
Ownership
SC 13G/A
Rock Springs Capital Management LP
15 Feb 22
4
Change in insider ownership
9 Aug 21
SC 13G/A
Stonepine Capital Management, LLC
9 Aug 21
4
WILLIAM LUDLAM
5 Aug 21
4
Roni Mamluk
5 Aug 21
4
Scott Minick
5 Aug 21
4
JOHN A SCARLETT
5 Aug 21
4
DAVID M STACK
5 Aug 21
4
JOHN F THERO
5 Aug 21
4
Anand Varadan
5 Aug 21